Page last updated: 2024-08-22

vidarabine and Rheumatoid Arthritis

vidarabine has been researched along with Rheumatoid Arthritis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donaldson, SL; McGonagle, DG; Owen, RG1
Alexandrova, IY; Grishina, GV; Kozlov, VA; Makarov, SV; Minaev, YL; Mishchenko, OV; Rossiev, VA; Semagina, OV1
Barr, WG; Brush, M; Burt, RK; Oyama, Y; Quigley, K; Statkute, L; Traynor, A; Verda, L; Yaung, K1
Kneba, M; Moosig, F; Schoch, R1
Boumpas, DT; Davis, JC; Fessler, BJ; Fleisher, TA; Klippel, JH; McInnes, IB; Pillemer, S; Tassiulas, IO; Wilder, R; Yarboro, CH1
Bambara, LM; Biasi, D; Caramaschi, P; Carletto, A1
Kashyap, A; Snowden, J1

Reviews

2 review(s) available for vidarabine and Rheumatoid Arthritis

ArticleYear
[T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome].
    Zeitschrift fur Rheumatologie, 2006, Volume: 65, Issue:5

    Topics: Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Felty Syndrome; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Leukemia, T-Cell; Methotrexate; Vidarabine

2006
Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
    The Journal of rheumatology. Supplement, 2001, Volume: 64

    Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Busulfan; Carmustine; Cyclophosphamide; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Melphalan; Podophyllotoxin; Radiotherapy, Adjuvant; Transplantation Conditioning; Transplantation, Autologous; Vidarabine

2001

Trials

2 trial(s) available for vidarabine and Rheumatoid Arthritis

ArticleYear
High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
    The Journal of rheumatology, 1998, Volume: 25, Issue:9

    Topics: Antigens, CD; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Lymphocyte Count; Male; Middle Aged; Phenotype; Platelet Count; Time Factors; Treatment Outcome; Vidarabine

1998
Unsuccessful treatment with fludarabine in four cases of refractory rheumatoid arthritis.
    Clinical rheumatology, 2000, Volume: 19, Issue:6

    Topics: Arthritis, Rheumatoid; Disease Progression; Female; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Middle Aged; Prednisone; Treatment Failure; Vidarabine

2000

Other Studies

3 other study(ies) available for vidarabine and Rheumatoid Arthritis

ArticleYear
Prolonged remission of marginal zone lymphoma in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor agents.
    The Journal of rheumatology, 2014, Volume: 41, Issue:12

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Receptors, Tumor Necrosis Factor; Remission Induction; Rituximab; Treatment Outcome; Tumor Necrosis Factor-alpha; Vidarabine

2014
[The role and place of high-dose immunosuppressive therapy and autologous transplantation of hematopoietic stem cells for autoimmune diseases].
    Terapevticheskii arkhiv, 2016, Volume: 88, Issue:1

    Topics: Adult; Age Factors; Antilymphocyte Serum; Arthritis, Rheumatoid; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Melphalan; Multiple Sclerosis; Patient Acuity; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vidarabine

2016
Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism.
    Arthritis and rheumatism, 2004, Volume: 50, Issue:8

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antirheumatic Agents; Arthritis, Rheumatoid; CD3 Complex; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Sialic Acid Binding Ig-like Lectin 3; Transplantation Chimera; Vidarabine

2004